Predator Labs D3+
Natural health product licensed in Canada
- Other names
- D3+
- Licence holder
- Predator Labs
- NPN or DIN-HM
- 80096550
- Status
- Active licence
- Licence date
- 9 January 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
| Adolescentes | minimum: 14 years ; maximum: 18 years | 1 Capsule | 1 Tous les jours |
| Adolescentes | minimum: 9 years ; maximum: 13 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Aide à l'absorption (et à l'utilisation) du calcium et du phosphore. Aide à la formation des os et des dents solides. Aide au développement et au maintien des os et des dents. Aide au maintien/soutien des fonctions/du système immunitaire(s). Aide les fonctions immunitaires. La consommation de calcium, lorsqu'elle s'accompagne d'un apport suffisant en vitamine D, d'une alimentation saine et de la pratique régulière d'une activité physique, peut réduire le risque d'ostéoporose.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80096550
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.